483
Kedrion Biopharma Inc.FDA 483 - Kedrion Biopharma Inc.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kedrion BioPharma, Inc. in Melville, NY, a biologic manufacturer, revealed significant deficiencies in their production of RhoGAM. The firm failed to follow written production and process control procedures, inadequately investigated deviations, lacked established procedures for microbiological contamination control, and did not exercise appropriate data integrity controls over computer systems used for PPQ lots.
- Company
- Kedrion Biopharma Inc.
- Product Type
- Biologics
Open in Dashboard
ID · 4bb0d998-5d67-433f-9727-8746fe93caff